GLP-1 agonists have transformed weight management, but they come with a retention problem. More than 64% of adults on GLP-1s quit within a year, driven off by nausea, vomiting and
If you caught our previous post about SlimSEB™‡, you already know it is grounded in a foundation of science to support metabolic health, for everyone from biohackers tracking each glucose
You’ve heard us talk about SlimSEB™ before. We’ve been buzzing about it since the earliest data started rolling in, and for good reason.
SlimSEB™ is an advanced, research-backed blend of enzymes,
Millions of people are using GLP-1 drugs. Millions more are coming off them. Tens of millions are watching from the sidelines: wanting to lose weight, but unable to afford hefty
GLP-1 agonists have rewritten the rules of weight management almost overnight—and in the process created one of the biggest nutrition challenges (and opportunities) formulators have seen in decades.
For brands paying